Dr. Bottinor earned her medical degree and completed her internal medicine residency at Virginia Commonwealth University in Richmond, Virginia. During her residency she developed an interest in clinical outcomes-based research and studied the relationship between contrast allergy and short- and long-term outcomes in patients undergoing angiography. She completed her general cardiology fellowship at University of Louisville. It was during her fellowship that she developed an interest in cardio-oncology and, under the mentorship of Dr. Carrie Lenneman, helped design a cardio-oncology curriculum. Dr. Bottinor continued her research endeavors and investigated the cardiovascular effects of combination human epidermal growth factor receptor antagonism with Pertuzumab and Transtuzumab in patients with breast cancer. She is board certified in echocardiography and nuclear cardiology and has published on the role of echocardiography and novel echocardiographic techniques in pre-clinical detection of cancer-related cardiotoxicity. In addition, she has contributed to sources for patient education, including the American College of Cardiology CardioSmart webpage. To date she has seven first-author publications. Most recently, she has been completing an advanced fellowship in cardio-oncology under the tutelage of Dr. Javid Moslehi. Her current research focuses on cardiovascular toxicities associated with vascular endothelial growth factor (VEGF) inhibitors. Her long-term career goal is to improve clinical care and outcomes for patients with cancer and cancer survivors by improving understanding of the cardiovascular toxicities of novel anti-cancer agents.